Naveris

Risk score

57

Headquarters

Flag of United States of AmericaUnited States of America

Naveris has created highly sensitive blood examinations for tumors to facilitate early detection in the general asymptomatic population, real-time tracking of progress in patients receiving therapy, and identification of cancer reappearance in patients in remission. Our examinations utilize innovative internal technology to capture and examine cancer-related DNA in blood plasma with heightened sensitivity in comparison to current circulating tumor DNA tests.